Current management and future strategies of gastric cancer.
about
Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancersGastric cancer: Current status of lymph node dissectionAdjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients?Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer.Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.Trends and results in treatment of gastric cancer over last two decades at single East European centre: a cohort studyUndervalued criteria in the evaluation of multimodal trials for upper GI cancers.miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer.Pathologic and oncologic outcomes in locally advanced gastric cancer with neoadjuvant chemotherapy or chemoradiotherapyMiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer.In vitro-activated tumor-specific T lymphocytes prolong the survival of patients with advanced gastric cancer: a retrospective cohort studyLymph node ratio is a better prognosticator than lymph node status for gastric cancer: A retrospective study of 138 cases.The assessment of the oncological safety margin of insufficient lymph node dissection in pT2 (pm) gastric cancer.The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis.Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer.HMGA2 regulates CD44 expression to promote gastric cancer cell motility and sphere formation.Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2Grifolin exhibits anti-cancer activity by inhibiting the development and invasion of gastric tumor cells.MicroRNA-200c regulates the sensitivity of chemotherapy of gastric cancer SGC7901/DDP cells by directly targeting RhoE.miR-874 Inhibits cell proliferation, migration and invasion through targeting aquaporin-3 in gastric cancer.Effect of doxorubicin, oxaliplatin, and methotrexate administration on the transcriptional activity of BCL-2 family gene members in stomach cancer cells.BMI and lymph node ratio may predict clinical outcomes of gastric cancer.Paclitaxel combined with harmine inhibits the migration and invasion of gastric cancer cells through downregulation of cyclooxygenase-2 expressionMajor early complications following open, laparoscopic and robotic gastrectomy.The anticipating value of PLK1 for diagnosis, progress and prognosis and its prospective mechanism in gastric cancer: a comprehensive investigation based on high-throughput data and immunohistochemical validation.Significance of aquaporins' expression in the prognosis of gastric cancer.Feasibility and Effects of a Postoperative Recovery Exercise Program Developed Specifically for Gastric Cancer Patients (PREP-GC) Undergoing Minimally Invasive Gastrectomy.
P2860
Q26751068-DC58E21F-898E-48C3-A15E-CA45AA9C7B39Q26766091-F64CD2A0-C19E-496A-AB68-503BF14946DAQ26774533-7C6E43EC-2778-4FAA-8C0D-9A3AEA7B9F32Q34255463-7C406B45-9CBA-43BD-AB5C-CF9844053700Q34371426-EE36DFB1-5507-482B-94DD-BE51220D7239Q34643128-F6218176-C4E7-4D0A-B427-F53AC27A0654Q34699973-46A7CE83-1014-4531-B28F-7CD95BF0CE46Q36525110-C6B7B163-04FA-4674-BE7E-43E4CCFA1DA9Q36872781-95865C28-6E44-4E3F-97B2-348455AA5D42Q36905819-24CC8891-F519-4BEA-A349-056AC2FF1FBBQ37042451-325ED845-5FA3-4CD0-ACC5-F9B71323701CQ37325956-97CEA40A-730B-4A1A-9492-76965CDF2F8AQ37418855-596EE5FF-BAD2-4C81-83F2-0D2FC7CAC3BCQ37636611-F8DD855E-436B-475E-AF7C-0D82870A24ACQ37672239-BADF52E9-7F8C-4720-BEC5-D2DC0995681AQ37679995-7F8AFE92-B86B-4C40-B4C7-925F3796C36DQ38704737-45C38E4D-A8B6-4D1D-88DE-BB2157E56DDDQ38828580-BF657E27-699C-4547-9022-5C88F13433EEQ38957899-67FF3AF5-64A5-4F52-819D-419F98D0AE53Q39131245-5327C4D2-2DA7-4830-9877-F4249BCBA057Q39134990-3DC9704B-5BA4-4C38-8EA8-1570FD40AA74Q39136321-88C8A35A-7686-4231-808B-52DBDED8B47CQ39257645-77DE21BC-DF53-4C89-9819-49D4FD45FAABQ41957403-B2ED75F2-9684-4740-A7AE-925718802A78Q42671093-6D8F2F51-21B5-4785-B71C-11A48A2DC345Q47143539-9B77100F-0E62-468A-A0BF-1932936B1C86Q55356248-78EB1258-1B4B-43AD-851A-93F05D2372F7Q55437607-6AB7957E-B4F1-42ED-B63D-A66C531A93D6
P2860
Current management and future strategies of gastric cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Current management and future strategies of gastric cancer.
@ast
Current management and future strategies of gastric cancer.
@en
type
label
Current management and future strategies of gastric cancer.
@ast
Current management and future strategies of gastric cancer.
@en
prefLabel
Current management and future strategies of gastric cancer.
@ast
Current management and future strategies of gastric cancer.
@en
P2860
P50
P1476
Current management and future strategies of gastric cancer
@en
P2093
Kyung Min Kim
P2860
P304
P356
10.3349/YMJ.2012.53.2.248
P5008
P577
2012-03-01T00:00:00Z